CLOFARABINE, MELPHALAN AND THIOTEPA REDUCED-INTENSITY CONDITIONING CHEMOTHERAPY ALONG WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE-BASED GRAFT VERSUS HOST DISEASE PROPHYLAXIS FOR ALLOGENEIC STEM CELL TRANSPLANT

被引:0
|
作者
Verduzco, Alejandro Del Rio [1 ]
Go, Aileen [1 ]
Kodali, Murali [1 ]
Ulrickson, Matthew [1 ]
De Padova, Nicolas [1 ]
Smith, Eric [1 ]
Komerdelj, Ivan [1 ]
Heers, Hayley [1 ]
Brookes, Jennifer [1 ]
Pebler, Haley [1 ]
Yasuda, Rachael [1 ]
Nath, Rajneesh [1 ]
机构
[1] Banner MD Anderson Canc Ctr, Gilbert, AZ USA
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P202
引用
收藏
页码:283 / 284
页数:2
相关论文
共 50 条
  • [31] Sirolimus and Post-Transplant Cyclophosphamide as Graft-versus-Host Prophylaxis in Patients Undergoing Matched Allogeneic Peripheral Blood Stem Cell Transplantation
    Ulrickson, Matthew
    Damghani, Faraz
    Yancey, Kristina
    Mohammed, Reeshma
    Davies, Kayla
    Rangan, Pooja
    De Padova, Nicolas
    Go, Aileen
    Kodali, Murali
    Nath, Rajneesh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S450 - S451
  • [32] Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant
    Greco, Raffaella
    Lorentino, Francesca
    Albanese, Serena
    Stanghellini, Maria Teresa Lupo
    Giglio, Fabio
    Piemontese, Simona
    Clerici, Daniela
    Lazzari, Lorenzo
    Marcatti, Magda
    Mastaglio, Sara
    Xue, Elisabetta
    Farina, Francesca
    Pavesi, Francesca
    Assanelli, Andrea
    Carrabba, Matteo G.
    Marktel, Sarah
    Vago, Luca
    Bonini, Chiara
    Corti, Consuelo
    Bernardi, Massimo
    Ciceri, Fabio
    Peccatori, Jacopo
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (09): : 776.e1 - 776.e13
  • [33] Haploidentical Stem Cell Transplant with Post-Transplant Cyclophosphamide with Busulfan, Fludarabine and Thiotepa Conditioning for Children with Thalassemia Major
    Yadav, Satya Prakash
    Sharma, Anil
    Kapoor, Rohit
    Chatterjee, Goutomi
    Rastogi, Neha
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S218 - S219
  • [34] Outcomes with Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
    Shahzad, Moazzam
    Iqbal, Qamar
    Zaidi, Sara J.
    Shah, Amna Y.
    Sulaiman, Reem
    Ahmed, Mamoon
    Naeem, Ammad
    Daud, Sorosh
    Anwar, Iqra
    Chaudhary, Sibgha Gull
    Hematti, Peiman
    Abhyankar, Sunil H.
    McGuirk, Joseph P.
    Mushtaq, Muhammad Umair
    BLOOD, 2022, 140 : 12884 - 12885
  • [35] Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in patients with inherited disorders undergoing allogeneic stem cell transplantation (allo-HSCT)
    Bykova, Tatiana
    Osipova, Anna
    Ovechkina, Varvara
    Galimov, Alexander
    Alyanskyi, Alexander
    Moiseev, Ivan
    Semenova, Elena
    Zubarovskaya, Ludmila
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2019, 54 : 298 - 299
  • [36] Reduced-intensity conditioning for allogeneic stem cell transplant in primary immune deficiencies
    Chiesa, Robert
    Veys, Paul
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (03) : 255 - 266
  • [37] Improved Outcomes Using Tacrolimus/Sirolimus for Graft-versus-Host Disease Prophylaxis with a Reduced-Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant as treatment of Myelofibrosis
    Snyder, David S.
    Palmer, Joycelynne
    Gaal, Karl
    Stein, Anthony S.
    Pullarkat, Vinod
    Sahebi, Firoozeh
    Vora, Nyana
    Nakamura, Ryotaro
    Forman, Stephen J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : 281 - 286
  • [38] Post-transplant cyclophosphamide as a graft versus host prophylaxis in pediatric haploidentical hematopoietic stem cell transplantation - case series
    Wawrzyniak-Dzierzek, Elzbieta
    Gajek, Kornelia
    Gorczynska, Ewa
    Kalwak, Krzysztof
    Ussowicz, Marek
    BONE MARROW TRANSPLANTATION, 2018, 53 : 713 - 714
  • [39] Post-transplant cyclophosphamide versus methotrexate-based regimen as graft-versus-host disease prophylaxis after allogeneic haematopoietic stem cell transplantation in patients with acute leukaemia
    Elshamy, A. N.
    Abdelmohsen, E. A.
    Denewer, M. A.
    Mabed, M. N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 5 - 6
  • [40] Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide
    Junichi Sugita
    Yusuke Kagaya
    Toshihiro Miyamoto
    Yasuhiko Shibasaki
    Koji Nagafuji
    Shuichi Ota
    Tatsuo Furukawa
    Miho Nara
    Koichi Akashi
    Shuichi Taniguchi
    Mine Harada
    Keitaro Matsuo
    Takanori Teshima
    Bone Marrow Transplantation, 2019, 54 : 432 - 441